miRNAs as modulators of neuroinflammation and excitotoxicity: Implications for stroke therapeutics
Mohammed S Elballal,Osama A Mohammed,Mohamed Bakr Zaki,Ahmed I Abulsoud,Manar Mohammed El Tabaa,Ola Elazazy,Mai A Abd-Elmawla,Walaa A El-Dakroury,Sherif S Abdel Mageed,Ahmed A Rashad,Nourhan M Abdelmaksoud,Mahmoud A Elrebehy,Yousra Nomier,Mustafa Ahmed Abdel-Reheim,Mamdouh A Oraby,Ahmed S Doghish,Mohammed S. Elballal,Osama A. Mohammed,Ahmed I. Abulsoud,Mai A. Abd-Elmawla,Walaa A. El-Dakroury,Sherif S. Abdel Mageed,Ahmed A. Rashad,Nourhan M. Abdelmaksoud,Mahmoud A. Elrebehy,Mamdouh A. Oraby,Ahmed S. Doghish
DOI: https://doi.org/10.1016/j.prp.2024.155093
IF: 3.309
2024-01-01
Pathology - Research and Practice
Abstract:Stroke is a widespread neurological disorder associated with physical disabilities, mortality, and economic burden. In recent decades, substantial progress has been achieved in reducing the impact of this public health problem. However, further understanding of the pathophysiology of stroke and the underlying genetic pathways is required. The pathological mechanisms of stroke comprise multifaceted molecular cascades regulated by various microRNAs (miRNAs). An increasing number of studies have highlighted the role of miRNAs, which have received much attention during the last decades as an important class of post-transcriptional regulators. It was shown that miRNAs exert their role in the etiology of stroke via mediating excitotoxicity and neuroinflammation. Additionally, miRNAs could be helpful as non-invasive or minimally invasive biomarkers and therapeutic agents. Thus, the current review focused on the interplay of these miRNAs in stroke pathology to upgrade the existing therapeutic strategies.
pathology